PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2017; 12(11): e0187746.
Published online 2017 November 22. doi:  10.1371/journal.pone.0187746
PMCID: PMC5699804

Chronic post-traumatic intramedullary lesions in dogs, a translational model

Neringa Alisauskaite, Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Visualization, Writing – original draft, Writing – review & editing,1,* Ingo Spitzbarth, Conceptualization, Data curation, Investigation, Resources, Writing – original draft,2,3 Wolfgang Baumgärtner, Data curation, Investigation, Project administration,2,3 Peter Dziallas, Data curation, Methodology, Resources,1 Sabine Kramer, Data curation, Resources,1 Ricarda Dening, Data curation, Resources,1 Veronika Maria Stein, Conceptualization, Project administration, Supervision,1,3 and Andrea Tipold, Conceptualization, Investigation, Methodology, Project administration, Supervision, Visualization, Writing – review & editing1,3
Carlos E. Ambrósio, Editor

Abstract

Objectives

Post-traumatic intramedullary myelopathies and cavitations are well described lesions following spinal cord injury (SCI) in humans and have been described in histopathological evaluations in dogs. Human intramedullary myelopathies/cavitations are associated with severe initial SCI and deterioration of clinical signs. Canine intervertebral disc extrusions share similarities with SCI in humans. In this descriptive study, magnetic resonance imaging (MRI) findings in spinal cords of dogs suffering from chronic post-traumatic myelopathies, including cavitations, are elucidated. An additional aim of the study was to compare diagnostic imaging and histopathological findings and identify similarities between human and canine chronic post-traumatic spinal cord lesions.

Methods

Thirty-seven dogs with thoracolumbar SCI and one or more 3Tesla MRI investigations more than 3 weeks after SCI were included. Extent of intramedullary lesions and particularly cavitations were evaluated and measured in sagittal and transverse MRI planes. These data were compared with clinical data.

Results

A total of 91.9% of study patients developed chronic intramedullary lesions, and 86.5% developed intramedullary cavitations. Paraplegia without deep pain perception at initial examination was significantly associated with longer chronic myelopathies/cavitations (P = 0.002/P = 0.008), and with larger maximal cross-sectional area (mCSA) of the lesions (P = 0.041/0.005). In addition, a non-ambulatory status after decompressive surgery was also associated with the development of longer intramedullary lesions/cavitations (P<0.001) and larger lesion mCSA (P<0.001/P = 0.012). All dogs with negative outcome developed myelopathies/cavitations. In the group of 21 dogs with positive outcome, 3 did not develop any myelopathies, and 5 did not develop cavitations.

Conclusions

Development of chronic intramedullary lesions/cavitations are common findings in canine SCI. Extensive chronic intramedullary lesions/cavitations reflect a severe initial SCI and negative clinical outcome. This supports the hypothesis that chronic spinal cord changes following SCI in humans share similarities with canine chronic spinal cord changes after spontaneous intervertebral disc extrusion.

Introduction

Human and canine intervertebral disc herniation (IVDH) and the consequent spinal cord pathology differ extensively. Disc protrusions are common in humans [1]. In the thoracic area, symptomatic IVDHs are rare [24]. In the lumbar area, they commonly occur at the level of L4-L5 and L5-S1, where peripheral nerves are affected, causing milder clinical symptoms [24]. In contrast, IVD extrusions are common in dogs, causing contusive and compressive lesions of the spinal cord resembling spinal cord injuries (SCI) after external trauma in humans, making the dog a suitable animal model for SCI [57].

The most commonly seen chronic intramedullary pathologies in histopathological studies of post-traumatic SCI include spinal cord degeneration, atrophy, demyelination, gliosis, malacia, necrosis and subsequent cavitations [5, 812].

Non-cavitational myelopathies in human studies are recognised as hyperintense ill-defined intramedullary areas with a less intense signal in comparison to cerebrospinal fluid (CSF) signal in T2 weighted magnetic resonance images (T2W MRI) [1317]. These areas are described as hypointense or isointense areas in T1 weighted images (T1WI) [1316]. In canine patients with chronic spinal cord changes, MRI features of non-cavitational intramedullary lesions have been poorly described. Few studies have observed intramedullary hyperintense signals in T2WI MR images of dogs with chronic paraplegia after acute IVDH [18, 19].

In addition to the described myelopathies, cavitation and/or syringomyelia might be observed. In human MRI studies, syringomyelia is defined as a tubular CSF signal intensity [14, 17]. The distinction between post-traumatic cavitations and syringomyelia is cumbersome, but most authors agree that cavitations are more restricted to the SCI epicentre lesions, while syringomyelia extends beyond the limits of SCI [14, 16, 17]. Intramedullary cavitations and/or syringomyelia in MRI of dogs as well as in humans are seen as hyperintense intraparenchymal signals with well-defined margins (isointense or slightly hypointense to CSF signal) in T2WI and hypointense in T1WI [20, 21].

The incidence of post-traumatic chronic intramedullary changes and intramedullary cavitations/syringomyelia in human patients is still uncertain, but is reported to reach up to 80% and 51%, respectively [14, 22, 23]. Unsuccessful outcomes after acute IVDH have been observed to be associated with severe chronic histopathological changes in the spinal cord parenchyma of canine patients [5, 8, 9, 11]. However, dogs that underwent control MRI examinations after successful IVDH treatment had no observable changes in MR images of their spinal cords [24]. Hyperintensity in T2WI in the initial MRI of dogs suffering from acute intervertebral disc herniations is well described and is associated with a worse prognosis for the patient [25, 26]. However, the features of chronic post-traumatic intramedullary changes, including post-traumatic syringomyelia in MRI have not yet been described in dogs.

It has been observed in human patients that myelopathies and cavitations/syringomyelia are associated with severity of initial clinical signs [1416, 27], post-traumatic recovery [14, 16] and spinal canal compromise [27].

The aim of the study was to describe chronic intramedullary lesions detectable in MR images following SCI in dogs and to compare the features of the intramedullary lesions with the clinical data. The hypotheses were that extensive myelopathies/cavitations are associated with severe initial SCI, negative outcome and higher number of manipulations on the spinal cord. Therefore, the extent of chronic intramedullary lesions/cavitations was compared with the initial neurological status and the presence of intramedullary hyperintensity in initial MR images. In addition, the extent of myelopathies/cavitations was compared to the ambulation status of the patients following treatment and the amount of decompressive surgeries performed. Spinal cord atrophy was hypothesised to be related to negative outcome of the patients. Therefore, the spinal cord diameter reduction in the lesion epicentre was compared to the outcome.

Materials and methods

Clinical settings

The database of the Small Animal Clinic of the University of Veterinary Medicine Hannover from 2010 to 2014 was reviewed to identify canine patients with chronic SCI. The following inclusion criteria were used to select the patients: body weight less than 20 kg, history of thoracolumbar spinal cord injury (mainly IVDH), which has been confirmed with MRI, paraplegic state at presentation in the veterinary hospital with present or absent deep pain perception (grade IV or V [28]), 3Tesla MRI investigations performed 3 weeks or later following spinal cord trauma. All patients with further lesions in their spinal cords, with the exception of mild intervertebral disc protrusions, were excluded from the study.

Part of the recruited animals were involved in another study (the permission was obtained from the Lower Saxony State Office for Consumer Protection and Food Safety, File Number 33.9-42502-04-11/0661), and other animals were retrospectively searched in the database of the Small Animal Medicine and Surgery Department of the University of Veterinary Medicine in Hannover. Dogs were anaesthetised and/or euthanised according to ethical principles using different medications, including acepromazine, levomethadone, propofol, isoflurane and pentobarbital. All efforts were made to minimise suffering. Approval was obtained from all dog owners to perform the study. An additional permission from the State Office for Consumer Protection and Food Safety was not applicable for the project, because of the retrospective origin of the study.

Based on the severity of neurological dysfunction, neurological examination results were summarised as Grades I, II, III, IV or V [28]:

  • Grade I spinal hyperesthaesia only
  • Grade II ambulatory paraparesis
  • Grade III non-ambulatory paraparesis
  • Grade IV paraplegia with present deep pain perception
  • Grade V paraplegia with absent deep pain perception

Information about neurological grade immediately after SCI was not available for 10 patients because they were presented to veterinarians who referred the cases only in the subacute or chronic stage of the disease (Tables (Tables11 and and2).2). All 10 of these patients were non-ambulatory at the presentation to the referring veterinarians (Grade III-V).

Table 1
Signalment, clinical and initial imaging data of patients with negative outcome.
Table 2
Signalment, clinical and initial imaging data of patients with positive outcome.

All clinical data were reviewed, including age, breed, sex, body weight, clinical history, information about applied treatment and outcome of the patients. Follow-up was available for at least 7 months after SCI, except in the patients that died or were euthanised upon request of the owners (Table 1).

The time interval between onset of paraplegia and adequate decompression of the spinal cord was noted (Tables (Tables11 and and2).2). Decompression was considered adequate when MRI observers subjectively agreed that the spinal cord was not compromised.

The number of decompressive surgeries performed on study patients, including the ones performed by other veterinary facilities, was recorded. The outcome was grouped into two categories:

  • Negative—animals did not regain ambulation within 7 months after presentation in the hospital or were euthanised/died spontaneously without showing signs of neurological improvement;
  • Positive–animals returned to ambulatory state within 7 months following SCI (≥grade II).

MRI examinations were performed using a 3.0T Philips Achieva MRI scanner (Phillips Medical Systems, Eindhoven, Netherlands) in all patients, and a 15-channel SENSE (sensitivity encoding) spine coil was applied. Spin echo T1W transverse (TR = 491.6, TE = 8, slice thickness = 2 mm), T2W transverse (TR = 8418.8, TE = 120, slice thickness = 2 mm), T2W FLAIR transverse (TR = 10000, TE = 140, slice thickness = 3.5 mm) and T2W sagittal (TR = 3100, TE = 120, slice thickness = 1.8 mm) images were acquired.

Decompressive surgeries were performed in all dogs, in which spinal cord compression was confirmed in diagnostic imaging. To decompress the spinal cord, a standard hemilaminectomy was performed using the paramedian approach to the facet joints and accessory processes of the vertebra [28].

Imaging data analysis

MRI images were analysed, and measurements were made in sagittal and transverse T2W, T1W and FLAIR MRI views using measurement and marking tools installed in the EasyImage image processing software (EasyImage®, Hannover, Germany). MR images were reviewed by two board certified neurologists (A.T. and V.S.).

All 37 patients had T2W images available in all MR investigations. Other available sequences are listed in Table 3. The initial SCI location (epicentre) in MRI was defined as the location of IVDH and spread disc material compressing the spinal cord. In 26 dogs, acute intramedullary changes in the spinal cord could be retrospectively evaluated on initial MRI examinations performed immediately (≤48 hours) after SCI.

Table 3
Time points of MRI investigations following SCI.

Chronic intramedullary changes were assessed in each study patient using MRI investigations performed 3 weeks or later following SCI. The time of MRI investigations in regard to acute SCI was recorded. Time points of follow-up MRI examinations of chronic lesions varied widely among the patients and were divided into 9 groups for simplification (Table 3).

Intramedullary cavitations were defined as a well demarcated hyperintense (equal to CSF or slightly lower) signal in T2WI and hypointense signal in T1WI and/or FLAIR images in spinal cord parenchyma. Post-traumatic syringomyelia was considered a cystic intramedullary lesion extending beyond the margins of the SCI epicentre [14, 16, 17]. Intramedullary lesions were defined as all abnormal intraparenchymal spinal cord signal intensities in MRI. Such areas included non-cavitational myelopathies (ill-demarcated lesions, hyperintense in T2WI in comparison to surrounding spinal cord parenchyma signal, but less signal intensity than surrounding CSF) and well demarcated cavitations as described above (Fig 1).

Fig 1
Transverse T2W and T1W MR images of intramedullary lesions/cavitations at the level of the SCI epicentre in the 3 dogs that were subsequently submitted for post-mortem histopathological examination.

In all MRI examinations 3 weeks post-SCI or later, the following features were investigated: SCI location (epicentre), presence of intramedullary lesions, presence of intramedullary cavitations, location of intramedullary lesions in regard to SCI epicentre (cranially, caudally, both directions or restricted to SCI epicentre), length of intramedullary lesions and cavitations in sagittal MRI views, maximal cross-sectional area (mCSA) of spinal cord lesion in transverse views and degree of spinal cord diameter reduction.

To measure the extent of intramedullary lesions, we used the methods described previously [29]. The length of intramedullary lesions and intramedullary cavitations were compared to the length of second lumbar (L2) vertebral body length [30]. The L2 vertebral body was measured in sagittal T2WI from cranial to caudal end plates [26]. The extent of intramedullary lesion/cavitation was divided by the length of the L2 vertebral body and expressed as a number (Fig 2):

Lesion length (n) = Length of the lesion (mm) / L2 vertebral body length (mm)
Fig 2
Measurement of the length, maximal cross-sectional area (mCSA) of intramedullary lesions/cavitations and spinal cord diameter at the lesion epicentre.

The mCSA of spinal cord lesions in transverse MRI views was calculated by dividing the area of affected spinal cord parenchyma by the area of the whole spinal cord at the same level and multiplying by 100 (expressed in percentage) (Fig 1). For simplification, the mCSA was categorised as no lesion, mild (<35%), average (35–75%) and severe (75–100%) lesion.

mCSA (%) = Lesion area (mm2) / Spinal cord area (mm2)  ×  100

The diameter of the spinal cord in the SCI epicentre was measured in transverse MRI views in all dogs with chronic SCI and compared with the diameters of apparently normal spinal cord diameter cranially and caudally of the lesion (1 spinal cord segment cranially and caudally of the lesion epicentre in most cases) and expressed by number as normal (1–0.95), mildly (0.75–0.95), moderately (0.35–0.75) or severely (0–0.35) reduced (Fig 1) [26]. If the diameter of spinal cord fell into different categories in comparison with apparently normal spinal cord in the segment cranially and caudally, the higher category was chosen for evaluation of results. The following formula was used to express the degree of spinal cord diameter reduction at the SCI epicentre:

Spinal cord diameter reduction degree (n) = Diameter in SCI epicentre (mm) / Diameter cranially (caudally) to SCI epicentre (mm)

Two study patients died spontaneously at home, and 1 dog had to be euthanised on request of the owners. With the owners’ consent these dogs underwent routine necropsy at the Department of Pathology of the University of Veterinary Medicine Hannover. During necropsy, tissue samples of multiple organs, including the spinal cord, were collected and fixed in 10% non-buffered formalin, followed by embedding in paraffin wax. Three micrometre-thick serial sections of the spinal cord at the site of the epicentre were stained with haematoxylin and eosin and underwent histopathological examination. Pictures of the sections were taken with a Keyence Microscope (BZ-9000, Keyence Deutschland GmbH, Neu-Isenburg, Germany) and adjusted for contrast and brightness, if necessary. Histopathological changes were compared to MRI results.

Statistical analysis

Data obtained in the MRI investigations were compared to clinical data utilising different statistical tests (Student's t-test, chi-squared test and McNemar's tests) using the IBM® SPSS® Statistics software Version 23 (IBM Corp., USA). If multiple MRIs were performed on a patient at different time points, the latest one was used for the comparison with the clinical data. To test for associations between the extension of the lesions in sagittal views and qualitative clinical data, including hyperintense intramedullary signal in T2WI in initial MRI, number of decompressive surgeries, outcome and neurological grade before surgery, the Student's t-test was used. To determine the relationship between clinical data and the mCSA of lesions observed in transverse MRI views and degree of reduction of spinal cord diameter, the chi-squared test was used. On paired nominal data, such as positive/negative outcomes, and intramedullary lesions restricted to the SCI epicentre/extended lesions, McNemar's test was performed.

Results

Thirty-seven dogs fulfilled the inclusion criteria, 36 of which suffered from IVDH and 1 from a L3-L4 vertebral fracture. Twelve of f the 37 patients (32.4%) were diagnosed and treated in other veterinary facilities and were presented at the Small Animal Clinic of the University of Veterinary Medicine Hannover more than 48 hours after onset of paraplegia. Twenty-five of the 37 dogs (67.6%) were presented in the hospital within 48 hours following SCI.

Information about neurological grade at presentation, age, gender and breed distribution among study dogs, and number of decompressive surgeries performed on the patients are presented in Tables Tables11 and and2.2. Twenty-five of the 37 patients (67.6%) had 1 decompressive surgery, and 12 of the 37 (32.4%)–had 2 decompressive surgeries.

Outcomes were negative in 16 of the 37 (43.2%) study patients and positive in 21 of 37 (56.8%, Table 4). Three dogs, which were categorised as negative outcome patients, died within 11 months after SCI. One of them was euthanised 3 months after SCI on request of the owner, because of lack of improvement, and 2 died due to reasons not related to SCI 11 and 10 months post-SCI. The time interval between acute onset of paraplegia and adequate decompression ranged from 1 to 200 days (Tables (Tables11 and and2).2). Hemilaminectomies were performed on 28 of the 37 (75.7%) patients within 24 hours after SCI, on 5 of 37 (13.5%) between 24 hours and 48 hours following SCI and on 4 of 37 (10.8%) later than 48 hours after SCI (Table 3).

Table 4
Chronic intramedullary lesion, cavitation, mCSA and SCA distribution among patients with positive and negative outcome and initial neurological grades IV and V.

Imaging data immediately after SCI (≤48 hours) was available in 25 patients, and an intramedullary hyperintensive signal in T2WI in the initial MR examinations was detected in 18 of 25 (72%) dogs (Tables (Tables11 and and22).

Thirty-four of 37 (91.9%) study patients developed chronic intramedullary lesions, and 32 of 37 (86.5%) developed intramedullary cavitations. Median values of length of intramedullary lesions and cavitations were 3.17 and 1.24, respectively.

Lesion distribution in regard to lesion epicentre is illustrated in Tables Tables55 and and66.

Table 5
Initial SCI location, length and location of chronic intramedullary lesions/cavitations, mCSA of intramedullary lesions/cavitations and severity of spinal cord atrophy in patients with negative outcome.
Table 6
Initial SCI location, length and location of chronic intramedullary lesions/cavitation, mCSA of intramedullary lesions/cavitations and severity of spinal cord atrophy in patients with positive outcome.

Maximal CSA of intramedullary lesions/cavitations was measured in transverse MR images. Intramedullary lesions were mild (<35%) in 15 of 37 (40.5%) patients, average (35–75%) in 8 of 37 (21.6%) and severe (75–100%) in 11 of 37 (29.7%). Intramedullary cavitations were mild (<35%) in 18 of 37 (48.6%), average (35–75%) in 11 of 37 (29.7%) and severe (75–100%) in 3 of 37 (8.1%) (Tables (Tables4,4, ,55 and and66).

Reduction of spinal cord diameter was measured in all study patients. Seven of 37 dogs (18.9%) had no reduction of spinal cord diameter in follow-up MR images, 20 of 37 (54.1%) had a mild (0.75–0.95), 9 of 37 (24.35%) had a moderate (0.35–0.75) and 2.7% (1/37) had a severe (0–0.35) spinal cord diameter reduction (Tables (Tables4,4, ,55 and and66).

Three study patients (patient IDs 7, 11 and 16) died spontaneously or were euthanised and sent to the Department of Pathology for post-mortem examination. Comparable findings were observed at the spinal cord epicentre of all 3 dogs during pathological examination (Fig 3). Gross findings included adhesion of the spinal cord meninges with the bony spinal canal wall and degenerated intervertebral disk material, respectively (patient ID 7 and 16) (Table 4). Severe extensive (patient ID 11) and mild focal (patient ID 16) spinal cord atrophy with hourglass-like appearance was noted at the spinal cord epicentre and extending caudally. Histological examination of the spinal cord epicentres of all 3 cases revealed myelomalacia with a predominant manifestation within the spinal cord grey matter in patients 7 and 16, and affecting the complete neuroparenchyma in patient 11 (Fig 3) (Table 7). There was marked reactive infiltration of large phagocytic, so-called gitter cells as well as a proliferation of partially spindeloid glial cells, interpreted as gliosis. The white matter of patients number 7 and 16 exhibited varying degrees of multifocal myelin sheath dilatation, occasionally with axonal drop-out, infiltration of myelinophages and multifocal swelling of hypereosinophilic axons termed spheroids. Additional findings included osseous metaplasia of the dura mater, termed pachymeningitis ossificans, in 1 dog (patient ID 7), while dural calcification was noted in another case (patient ID 11) (Table 4). Overall, the histopathologic findings of intramedullary lesions in the epicentre highly mirrored the observations in the MRI of the patients (Figs (Figs22 and and33).

Fig 3
Overview of haematoxylin and eosin-stained sections of the spinal cord epicentre of the 3 dogs with severe, chronic spinal cord injury.
Table 7
Histopathological findings in the 3 patients (patient ID 7, 11 and 16).

Length of intramedullary lesions and intramedullary cavitations were compared with severity of initial SCI, defined as neurological grade immediately (≤48 hours) after SCI, and hyperintense intramedullary signal in T2WI in initial MRI examinations using Student's t-test. The number of decompressive surgeries and outcomes were also compared with the length of intramedullary lesions/cavitations using Student’s t-test.

The length of intramedullary lesions and cavitations was associated with the initial neurological status of the study patients. Dogs that presented with grade V were significantly more likely to develop longer intramedullary lesions and cavitations compared to dogs that initially presented with neurological grade IV (P = 0.002 and P = 0.008, respectively) (Table 4, Fig 4).

Fig 4
Association between length of chronic intramedullary lesions/cavitations and neurological grade following SCI (≤48 hours).

No association was found between the hyperintense intramedullary signal in T2WI in the initial MRI examination and the length of chronic intramedullary lesions and intramedullary cavitations (P = 0.207/P = 0.149).

Dogs that had 2 decompressive surgeries did not develop longer intramedullary lesions/cavitations compared to dogs that had 1 decompressive surgery (P = 0.383/P = 0.363).

The outcome was significantly associated with length of intramedullary lesions and cavitations (P<0.0001). A positive outcome was highly associated with shorter intramedullary lesions and cavitations and vice versa (Fig 5). Dogs with positive outcome had a median length of intramedullary lesions and cavitations of 1.66 and 0.36 in comparison with L2 vertebra length, respectively (Tables (Tables4,4, ,55 and and6).6). Dogs with negative outcome had median values of length of intramedullary lesions and cavitations of 5.32 and 4.22, respectively.

Fig 5
Association between length of chronic intramedullary lesions/cavitations and neurological outcome (P<0.0001).

Two variable tables were created to test the correlation between the outcome and lesion restriction to the SCI epicentre. Positive outcomes were negatively correlated with intramedullary lesions and intramedullary cavitations, extending beyond the lesion epicentre (weak negative correlation, simple kappa = -0.317/-0.375).

Eighteen dogs with positive outcomes developed intramedullary lesions (Tables (Tables44 and and6).6). Myelopathies were detected in all available MRI scans 3 weeks following SCI or later. For 5 dogs with positive outcomes, more than 1 MRI examination of chronic intramedullary lesions was available (Table 3). Intramedullary lesions and cavitations became more pronounced in the following MRI examinations in 4 and 3 patients, respectively. In 1 patient a regression of intramedullary lesion was observed, but the cavitation expanded. Intramedullary lesions in dogs with negative outcomes were detected in all MRI scans at all available time intervals after SCI (Tables (Tables44 and and5).5). Sixteen dogs with negative outcomes had more than 1 MRI performed more than 3 weeks after SCI (Table 3). The intramedullary lesions and cavitations expanded with time in 6 and 7 patients, respectively. In 1 case, cavitation was not detected in the first MRI scan in the time period between 3 weeks and 2 months after SCI, but was present in the following MRI scans.

Eighteen of the 37 study patients (48.65%) developed chronic cavitations, extending beyond the SCI epicentre. These cavitations were considered to be post-traumatic syringomyelias. Post-traumatic syringomyelias were detected in 6 of 21 (28.57%) dogs with positive outcomes and 12 of 16 (75%) of dogs with negative outcomes (Tables (Tables4,4, ,55 and and66).

To find an association between clinical data and mCSA of intramedullary lesions and cavitations, a chi-square test was used.

Dogs initially demonstrating neurological grades IV and V were statistically different in regard to mCSA of intramedullary lesions and intramedullary cavitations found in follow-up MRI studies in their spinal cords (P = 0.041/0.005). Dogs with neurological grade V at presentation had more extensive cavitations, observed in the transverse MRI planes, than dogs with grade IV.

Hyperintensity in T2W MRI immediately after SCI was associated with mCSA of intramedullary lesions (P = 0.004). On the other hand, a hyperintense intramedullary signal in T2WI immediately after SCI was not associated with mCSA of intramedullary cavitations (P = 0.095).

Maximal CSA of intramedullary lesions and cavitations was not associated with number of decompressive surgeries performed (P = 0.323/0.140).

Neurological outcome was significantly associated with mCSA of intramedullary lesions and intramedullary cavitations (P<0.001/P = 0.012). Dogs with positive outcome developed less extensive intramedullary lesions/cavitations compared to dogs with negative outcome.

A chi-squared test was applied to evaluate the association between degree of spinal cord diameter reduction and outcome. Reduction of spinal cord diameter was not associated with outcome (P = 0.078).

Discussion

In the current study, the MRI features of chronic intramedullary lesions following SCI in dogs were described, and the associations between imaging and clinical data were identified. Thirty-four of the 37 current study patients (91.9%) developed chronic intramedullary lesions, and 32 of 37 (86.5%) developed intramedullary cavitations. In human patients, the prevalence of post-traumatic intramedullary lesions reaches more than 80%, and cavitations (including post-traumatic syringomyelias) reach up to 51% [14, 22, 23]. The prevalence of post-traumatic intramedullary lesions/cavitations is lower in human SCI studies compared to our study. However, in human studies, initial neurological grade after SCI varied from mild to severe. In the current study, all dogs had severe neurological deficits ranging from non-ambulatory paresis to paraplegia, representing severe initial SCI.

In the current study, dogs that presented at the hospital with neurological grade V were more likely to develop more extensive (length and lesion mCSA) myelopathies and cavitations than dogs that presented with grade IV (Fig 4). This supports our hypothesis that more severe initial spinal cord trauma leads to extensive chronic intramedullary changes and cavitations. In human medicine, the presence of severe chronic spinal cord changes, including myelomalacia, spinal cord atrophy, cystic cavities and syringomyelia is also directly associated with severe initial SCI [15, 16]. The risk of development of post-traumatic syringomyelia in complete (absent sensory or motor function) initial SCI is higher than with milder neurological presentation [27, 3133]. Other authors could not confirm this association [22, 34]. However, in the latter studies, the extent of lesions was not considered (i.e., smaller cavitations restricted to the SCI epicentre were classified as syringomyelias) [22, 34].

All dogs in the current study with hyperintensities in initial MRIs (n = 18) developed intramedullary lesions in follow-up examinations, and 16 of them developed intramedullary cavitations. On the other hand, from 8 dogs without hyperintense signal in initial T2W MR images, 4 developed intramedullary lesions, while the other 4 dogs did not. Although the association between the length of intramedullary lesions/cavitations in sagittal MR images and preoperative hyperintensity in T2WI was not significant, a significant association was found between mCSA of chronic myelopathies and hyperintensities in the initial T2W MR images. Intramedullary hyperintensity in initial T2W MR images following SCI are thought to be associated with spinal cord oedema, contusion, inflammation, myelomalacia and necrosis in the spinal cord in human and canine patients [35, 36]. Initial MRI is used as one of the predictive factors for the outcome in dogs with SCI following acute IVDH. In the study of Ito et al., only 55% of paraplegic dogs with intramedullary hyperintensity following acute IVDH regained ambulation, whereas all dogs without initial T2W intramedullary hyperintensity regained ambulation [25]. Other studies involving dogs with various initial neurological grades only showed a tendency for dogs with intramedullary hyperintensity to have a poorer outcome [26, 30, 37]. A similar prognostic value of MRI for functional outcomes has been described in human patients after spinal cord trauma [3840].

In the current study, more extensive chronic intramedullary lesions/cavitations were strongly associated with worse neurological outcomes (Fig 5). It is known in veterinary medicine, that extensive syringomyelia can cause chronic pain, ataxia and mild paresis in dogs, but never plegia per se [4143]. We did not observe the formation of syringomyelia being linked to deterioration of clinical signs in dogs, but we speculate that it contributes to the lack of clinical improvement. Studies in human medicine have shown that the presence and extent of spinal cord cavitations/syringomyelia are associated with more severe clinical signs in follow-up examinations and with deterioration of clinical signs [14, 16, 35]. In veterinary medicine, there are limited data comparing outcome and MRI findings of chronic intramedullary changes following SCI. Nevertheless, the search for new treatment strategies in chronic paraplegic dogs is ongoing [18, 19, 44]. In transplantation studies, intramedullary hyperintensities and cavitations in T2W MR images in chronic paraplegic canine patients were detected a few months to several years following SCI [18, 19]. In a study performed by Forterre et al., dogs with positive outcome after IVDH surgery did not have any intramedullary changes in follow-up MRI examinations 12 weeks following acute SCI [24]. However, the initial neurological grade/T2W hyperintensity in the initial MRI examinations of these dogs are unknown, which means that the initial SCI could have been milder than in our study patients. In the current study, the outcome was considered to be positive when dogs regained ambulation, which leads to a certain limitation because rehabilitation time and final degree of paraparesis or ataxia were not considered. A weak correlation was found between location of intramedullary myelopathies/cavitations and neurological outcome of the patients. Lesions restricted to the SCI epicentre were associated with positive outcome, which is in agreement with earlier observations in humans [14, 35].

No association was found between the number of decompressive surgeries and the extent of intramedullary lesions and cavitations in sagittal and transverse MR images. The influence of spinal cord manipulation and spinal canal stenosis on development of different intramedullary changes is still in debate in human medicine [14, 27, 34]. It is strongly believed that scar formation in the dura mater and subarachnoid space may be the key mechanism in the formation of post-traumatic syringomyelia [4548]. It should be taken into consideration that human SCI is frequently associated with malalignment of the vertebral canal requiring other surgery techniques than the hemilaminectomy normally used according to the standard protocol in naturally occurring IVDH in dogs [28]. The current study is in line with other veterinary field studies, showing a benefit of multiple surgeries for functional outcome if they provide proper spinal cord decompression [24, 49]. One of the limitations of the study is the surgeon’s experience which was not considered. Surgeons’ experience was shown to be associated with neurological outcomes [50].

Thirty of 37 (81.1%) of our study patients had reduced diameters of their spinal cords, restricted to the SCI epicentre. Nevertheless, we could not find a significant association between the degree of diameter reduction of spinal cord and outcome of our patients. A small amount of white matter in the subpial region of the spinal cord in dogs may be enough to preserve motor function [7]. In human patients, spinal cord atrophy in MR images is defined as decreased anteroposterior diameter of the spinal cord, measuring 5 to 6 mm or less [16]. In canine patients, the exact extent has not been clearly defined, most probably because of spinal cord diameter size variation in different breeds. In more than 50% of human patients suffering from chronic paraplegia after spinal cord trauma, spinal cord atrophy is detected and restricted to the injury site [51]. These chronic changes in the spinal cord are not associated with formation of syringomyelia, but they are associated with a worse neurological outcome [16, 52].

One of the limitations of our study was the imprecision of manual intramedullary lesion measurement in the MR images [37].

To the authors’ knowledge, MRI features of chronic intramedullary changes have not been well described in veterinary medicine up to this point. Chronic intramedullary fluid-filled cavitations of our study dogs display the same imaging pattern as syringomyelia described in humans and dogs [13, 14, 16, 20]. Non-cavitational intramedullary changes detected in our patients‘ MR images resemble malacic changes as described in human patients and MRI features of ascending—descending myelomalacia in dogs [1214, 16, 36, 53]. However, chronic myelopathies following IVDH detected in our patients did not progress rapidly and were found primarily in the grey matter of the spinal cord. In 10 of our 21 patients (47.61%) that underwent more than 1 MRI examination at least 3 weeks following SCI, the intramedullary lesions did not increase with time. Unfortunately, we could not detect any clinical factors that contributed to the expansion of intramedullary lesions.

Histopathological examination of 3 of the study patients revealed severe myelomalacia with a predominant manifestation within the grey matter and variable extent into the white matter of the spinal cord. The degenerative changes were associated with a reactive response of phagocytic cells clearing necrotic debris. Moreover, there was reactive proliferation of partly spindeloid glial cells, most probably indicating reparative attempts in terms of glial scar tissue formation. Two of the dogs additionally displayed a reduced and hourglass-shaped diameter of their spinal cord at the lesion epicentre, thus indicating atrophic changes of the neuroparenchyma (Table 4) (Fig 3). Overall, the histopathological findings highly corresponded to the MRI data (Figs (Figs22 and and33).

Spinal cord cavitations are thought to be sequelae to myelomalacia/necrosis in the spinal cord in both humans and dogs [12, 45]. Initial spinal cord trauma may cause bleeding, contusion or oedema, subsequently leading to local necrosis of the parenchyma. Necrotic tissue is liquefied and replaced with a cavity, which is filled with fluid [12, 45]. In the human literature, it is speculated that cavities without continuous enlargement do not cause neurological problems, but cavities with progression in size are associated with neurological deterioration [14]. Several mechanisms have been suggested to explain the expansion of the cavity, but the intramedullary pulse pressure theory is the most widely accepted. According to this theory, increased pulse pressure in the spinal cord in comparison to the subarachnoid space leads to expansion of syringomyelia [45, 54]. In humans, syringomyelia with a tendency to grow is lined with dense tissue and surrounded by reactive gliosis [55]. In contrast, intramedullary fluid-filled cavitations, that are not associated with clinical signs, mostly have thin astrogliotic walls [55]. In 3 dogs in the current study, the spinal cords of which were investigated histologically, the linings surrounding the malacic/necrotic areas were considered to be rather thin and should represent the cavity without pressure. We speculate that this feature could have varied in different study patients.

Conclusions

In conclusion, we have confirmed that chronic intramedullary lesions/cavitations mirror the severity of initial trauma to the spinal cord and correspond to the neurological state in dogs. These findings are in line with human SCI investigations [14, 16, 27, 3133]. The number of decompressive surgeries in dogs is not associated with the extent of intramedullary lesions. This is partly in line with human SCI studies [34]. However, chronic reduction of spinal cord diameter was not associated with a worse outcome in the current study as it has been described in humans [16, 52].

The current study provides evidence that the canine patient with naturally occurring IVDH is a useful model for human SCI investigations.

Supporting information

S1 Table

Clinical and diagnostic imaging information of the study patients.

Number–patient number in veterinary hospital database.

Patient ID–number, corresponding to patient ID number in the manuscript.

Acute cases (+/-)—+ patients presented at the hospital in acute phase of SCI (<3 weeks following SCI);—patients presented at the hospital in chronic phase of SCI (>3 weeks).

Surgery at referring veterinarian (+/-)—+performed;—not performed.

MRI time points– 0 = before decompressive surgery; 1 = 1–3 weeks after decompression; 2 = 3 weeks-2 months; 3 = 2–5 months, 4 = 5–8 months, 5 = 8–11 months, 6 = 11–14 months, 7 = 14–17 months, 8 = 17–20, 9 = >20 months after adequate decompression.

SCA >3 weeks following decompression—0 = no atrophy; mild atrophy 1 = 0,75–0,95; average atrophy 2 = 0,35–0,75; severe atrophy 3 = 0–0,35 spinal cord diameter in SCI epicentre in comparison to normal spinal cord diameter.

Maximal CSA of intramedullary lesion—0 = no lesion, 1 = 1–35%, 2 = 35–75%, 3 = 75–100% of the spinal cord area.

T1W MRI examination—+ available,—not available.

FLAIR MRI examination—+ available,—not available.

Fluid-filled cavitations/syringomyelia—+ present;—not present.

Maximal CSA of intramedullary lesion– 0 = no lesion, 1 = 1–35%, 2 = 35–75%, 3 = 75–100% of spinal cord area.

Intramedullary hyperintensity in initial T2W MR images (+/-)—+ present;—not present; n.a. = not available.

(XLS)

Acknowledgments

We would like to thank Dr. Martin Beyerbach from the Institute for Biometry, Epidemiology and Information Processing of the University of Veterinary Medicine in Hannover for helping to conduct the statistical analyses of the data for the present study.

Funding Statement

The present project was partly supported by the German Research Foundation (FOR 1103, project TI 309/4-1). It covered the MRI examination and decompressive surgery expenses of the plegic dogs. No financial support was provided to the authors of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.

Data Availability

Data Availability

All relevant data are within the paper and its Supporting Information files.

References

1. McRae DL. Asymptomatic intervertebral disc protrusions. Acta radiol. 1956; 46(1–2): 9–27. [PubMed]
2. Arseni C, Nash F. Protrusion of thoracic intervertebral discs. Acta Neurochir. 1963; 11(1): 3–3.
3. Kumar R, Kumar V, Das NK, Behari S, Mahapatra AK. Adolescent lumbar disc disease: findings and outcome. Childs Nerv Syst. 2007. November 1;23(11): 1295–9. doi: 10.1007/s00381-007-0370-1 [PubMed]
4. Ma D, Liang Y, Wang D, Liu Z, Zhang W, Ma T, et al. Trend of the incidence of lumbar disc herniation: decreasing with aging in the elderly. Clin Interv Aging. 2013; 8:1047 doi: 10.2147/CIA.S49698 [PMC free article] [PubMed]
5. Smith PM, Jeffery ND. Histological and ultrastructural analysis of the white matter damage after naturally-occuring spinal cord injury. Brain Pathol. 2006; 16:99–109. doi: 10.1111/j.1750-3639.2006.00001.x [PubMed]
6. Jeffery ND, Smith PM, Lakatos A, Ibanez C, Ito D, Franklin RJ. Clinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy. Spinal Cord. 2006; 44(10):584–93. doi: 10.1038/sj.sc.3101912 [PubMed]
7. Levine JM, Levine GJ, Porter BF, Topp K, Noble-Haeusslein J. Naturally occuring disk herniation in dogs: an opportunity for pre-clinical spinal cord injury research. J. of Neurotrauma. 2010; 28:675–688. [PMC free article] [PubMed]
8. Griffiths IR. Some aspects of the pathology and pathogenesis of the myelopathy caused by disc protrusions in the dog. J Neurol Neurosurg Psychiatry. 1972; 35:403–413. [PMC free article] [PubMed]
9. Wright F, Palmer AC. Morphological changes caused by pressure on the spinal cord. Pathol Vet. 1969; 6:355–368. [PubMed]
10. Ryu HH, Kang BJ, Park SS, Kim Y, Sung GJ, Woo HM, et al. Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton’s jelly, and umbilical cord blood for treating spinal cord injuries in dogs. J Vet Med Sci. 2012; 74(12): 1617–1630. [PubMed]
11. Henke D, Vandevelde M, Doherr MG, Stöckli M, Forterre F. Correlations between severity of clinical signs and histopathological changes in 60 dogs with spinal cord injury associated with acute thoracolumbar intervertebral disc disease. Vet J. 2013; 198: 70–75. doi: 10.1016/j.tvjl.2013.04.003 [PubMed]
12. Vandevelde M, Higgins RJ, Oevermann A. Trauma. Veterinary Neuropathology: Essentials of Theory and Practice. New York, USA: Wiley-Blackwell; 2012.
13. Falcone S, Quencer RM. Green BA, Patchen SJ, Post MJ. Progressive posttraumatic myelomalacic myelopathy: imaging and clinical features. AJNR Am J Neuroradiol. 1994; 15(4):747–54. [PubMed]
14. Wang D, Bodley R, Sett P, Gardner B, Frankel HA. Clinical magnetic resonance imaging study of the traumatised spinal cord more than 20 years following injury. Paraplegia. 1996; 34(2): 65–81. [PubMed]
15. O'Beirne J, Cassidy N, Raza K, Walsh M, Stack J, Murray P. Role of magnetic resonance imaging in the assessment of spinal injuries. Injury. 1996; 24(3):149–54. [PubMed]
16. Silberstein M., Hennessy O. Implications of focal spinal cord lesions following trauma: evaluation with magnetic resonance imaging. Paraplegia. 1993; 31(3):160–7. doi: 10.1038/sc.1993.31 [PubMed]
17. Potter K, Saifuddin A Pictorial review: MRI of chronic spinal cord injury. Br J Radiol. 2003; 76(905):347–52. doi: 10.1259/bjr/11881183 [PubMed]
18. Penha EM, Meira CS, Guimarães ET, Mendonça MVP, Gravely FA, Pinheiro CMB, et al. Use of autologous mesenchymal stem cells derived from bone marrow for the treatment of naturally injured spinal cord in dogs. Stem Cells Int. 2014; published online 2014 Feb 25. doi: 10.1155/2014/437521 [PMC free article] [PubMed]
19. Feitosa ML, Sarmento CA, Bocabello RZ, Beltrão-Braga PC, Pignatari GC, Giglio RF, et al. Transplantation of human immature dental pulp stem cell in dogs with chronic spinal cord injury. Acta Cirurgica Brasileira. 2017. July;32(7):540–9. doi: 10.1590/s0102-865020170070000005 [PubMed]
20. Platt S, Freeman C. Neck and back pain In: Platt S, Olby N, editors. BSAVA manual of feline and canine neurology. 4th ed. Gloucester, UK: BSAVA; 2013. p. 260–261.
21. Gavin PR, Bagley RS. Practical Small Animal MRI. New York, USA: Wiley-Blackwell; 2009.
22. Backe HA, Betz RR, Mesgarzadeh M, Beck T, Clancy M. Post-traumatic spinal cord cysts evaluated by magnetic resonance imaging. Paraplegia. 1991; 29(9), 607–612. doi: 10.1038/sc.1991.89 [PubMed]
23. Squier MV, Lehr RP. Post-traumatic syringomyelia. J Neurol Neurosurg Psychiatry. 1994; 57(9), 1095–1098. [PMC free article] [PubMed]
24. Forterre F., Gorgas D., Dickomeit M., Jaggy A., Lang J., Spreng D. Incidence of spinal compressive lesions in chondrodystrophic dogs with abnormal recovery after hemilaminectomy for treatment of thoracolumbar disc disease: a prospective magnetic resonance imaging study. Vet Surg. 2010; 39(2), 165–172. doi: 10.1111/j.1532-950X.2009.00633.x [PubMed]
25. Ito D, Matsunaga S, Jeffery ND, Sasaki N, Nishimura R, Mochizuki M, et al. Prognostic value of magnetic resonance imaging in dogs with paraplegia caused by thoracolumbar intervertebral disk extrusion: 77 cases (2000–2003). J AmVet Med Assoc. 2005; 227(9), 1454–1460. [PubMed]
26. Ensinger EM, Flieshardt C, Boekhoff TM, Fork M, Kramer S, Tipold A. Magnetic resonance imaging findings in 34 dogs with cervical intervertebral disc disease: prognostic value? Kleintierpraxis. 2010; 55(10), 537–543.
27. Vannemreddy SS, Rowed DW, Bharatwal N. Posttraumatic syringomyelia: predisposing factors. Brit J Neurosurg. 2002; 16(3), 276–283. [PubMed]
28. Sharp NJH, Wheeler SJ. Small Animal Spinal Disorders. Diagnosis and Surgery. 2nd ed. Edinburgh, UK: Elsevier Mosby; 2005.
29. Risio LD, Adams V, Dennis R, McConnell F, Platt S. Magnetic resonance imaging findings and clinical associations in 52 dogs with suspected ischemic myelopathy. J Vet Intern Med. 2007; 21(6), 1290–1298. [PubMed]
30. Levine JM, Fosgate GT, Chen AV, Rushing R, Nghiem PP, Platt SR, et al. Magnetic resonance imaging in dogs with neurologic impairment due to acute thoracic and lumbar intervertebral disk herniation. J Vet Intern Med. 2009; 23(6):1220–6. doi: 10.1111/j.1939-1676.2009.0393.x [PubMed]
31. Kramer KM, Levine AM. Posttraumatic Syringomyelia; A Review of 21 Cases. Clin Orthop Relat Res. 1997; 334, 190–199. [PubMed]
32. Edgar R, Quail P. Progressive post-traumatic cystic and non-cystic myelopathy. Br J Neurosurg. 1994; 8(1), 7–22. [PubMed]
33. Schurch B, Wichmann W, Rossier AB. Post-traumatic syringomyelia (cystic myelopathy): a prospective study of 449 patients with spinal cord injury. J Neurol Neurosurg Psychiatry. 1996; 60(1):61–7. [PMC free article] [PubMed]
34. Ko HY, Kim W, Kim SY, Shin MJ, Cha YS, Chang JH, et al. Factors associated with early onset post-traumatic syringomyelia. Spinal cord. 2012; 50(9):695–8. doi: 10.1038/sc.2012.35 [PubMed]
35. Klekamp J, Samii M. Syringomyelia: Diagnosis and Treatment. Heidelberg, New York, USA: Springer-Verlag Berlin; 2002.
36. Coates JR. Acute disc disease. Specific emergencies In: Platt S, Garosi L. Small animal neurological emergencies. Manson Publishing, London; 2012, pp 399–416.
37. Griffin JF, Davis MC, Ji JX, Cohen ND, Young BD, Levine JM. Quantitative magnetic resonance imaging in a naturally occurring canine model of spinal cord injury. Spinal cord. 2015; 53(4):278–84. doi: 10.1038/sc.2014.244 [PubMed]
38. Shimada K, Tokioka T. Sequential MR studies of cervical cord injury: correlation with neurological damage and clinical outcome. Spinal Cord. 1991; 37(6), 410–415. [PubMed]
39. Mohanty SP, Bhat NS, Singh KA, Bhushan M. Cervical spinal cord injuries without radiographic evidence of trauma: a prospective study. Spinal cord. 2013; 51(11), 815–818. doi: 10.1038/sc.2013.87 [PubMed]
40. Miyanji F, Furlan JC, Aarabi B, Arnold PM, Fehlings MG. Acute Cervical Traumatic Spinal Cord Injury: MR Imaging Findings Correlated with Neurologic Outcome—Prospective Study with 100 Consecutive Patients. Radiology. 2007; 243(3), 820–827. doi: 10.1148/radiol.2433060583 [PubMed]
41. Hu HZ, Rusbridge C, Constantino-Casas F, Jeffery N. Histopathological investigation of syringomyelia in the Cavalier King Charles spaniel. J Comp Pathol. 2012; 146(2), 192–201. [PubMed]
42. Hu HZ, Rusbridge C, Constantino-Casas F, Jeffery N. Distribution of substance P and calcitonin gene-related peptide in the spinal cord of Cavalier King Charles Spaniels affected by symptomatic syringomyelia. Res Vet Sci. 2012; 93(1), 318–320. doi: 10.1016/j.rvsc.2011.08.012 [PubMed]
43. Plessas IN, Rusbridge C, Driver CJ, Chandler KE, Craig A, McGonnell IM, et al. Long-term outcome of Cavalier King Charles spaniel dogs with clinical signs associated with Chiari-like malformation and syringomyelia. Vet Rec. 2012; 171(20), 501 doi: 10.1136/vr.100449 [PubMed]
44. Escalhão CCM, Ramos IP, Hochman-Mendez C, Brunswick THK, Souza SAL, Gutfilen B, et al. Safety of Allogeneic Canine Adipose Tissue-Derived Mesenchymal Stem Cell Intraspinal Transplantation in Dogs with Chronic Spinal Cord Injury. Stem Cells Int. 2017; published online 2017 May 22. doi: 10.1155/2017/3053759 [PMC free article] [PubMed]
45. Shields CB, Zhang YP, Shields LB. Post-traumatic syringomyelia: CSF hydrodynamic changes following spinal cord injury are the driving force in the development of PTSM. Spinal Cord Injury In: Verhaagen J, Mcdonald JW., editors. Handbook of Clinical Neurology. Volume 109 Amsterdam, the Netherlands: Elsevier; 2002. 355 p. [PubMed]
46. Perrouin-Verbe B, Lenne-Aurier K, Robert R, Auffray-Calvier E, Richard I, Mauduyt DLGI, et al. Post-traumatic syringomyelia and post-traumatic spinal canal stenosis: a direct relationship: review of 75 patients with a spinal cord injury. Spinal Cord. 1998; 36(2), 137–143. [PubMed]
47. Williams B. Pathogenesis of post-traumatic syringomyelia. Brit J Neurosurg. 1992; 6(6), 517–520. [PubMed]
48. Cho KH, Iwasaki Y, Imamura H, Hida K, Abe H. Experimental model of posttraumatic syringomyelia: the role of adhesive arachnoiditis in syrinx formation. J Neurosurg. 1994; 80(1), 133–139. doi: 10.3171/jns.1994.80.1.0133 [PubMed]
49. Hettlich BF, Kerwin SC, Levine JM. Early reherniation of disk material in eleven dogs with surgically treated thoracolumbar intervertebral disk extrusion. Veterinary surgery. 2012; 41(2):215–20. doi: 10.1111/j.1532-950X.2011.00920.x [PubMed]
50. Bennaim M, Porato M, Jarleton A, Hamon M, Carroll JD, Gommeren K, Balligand M. Preliminary evaluation of the effects of photobiomodulation therapy and physical rehabilitation on early postoperative recovery of dogs undergoing hemilaminectomy for treatment of thoracolumbar intervertebral disk disease. Am J of Vet Res. 2017; 78(2):195–206. [PubMed]
51. Vaquero J, Zurita M. Cell transplantation in paraplegic patients: the importance of properly assessing the spinal cord morphology. Clin Transplant. 2013; 27(6), 968–971. doi: 10.1111/ctr.12267 [PubMed]
52. Curati WL, Kingsley DPE, Kendall BE, Moseley IF. MRI in chronic spinal cord trauma. Neuroradiology. 1992; 35(1), 30–35. [PubMed]
53. Okada M, Kitagawa M, Ito D, Itou T, Kanayama K, Sakai T. Magnetic resonance imaging features and clinical signs associated with presumptive and confirmed progressive myelomalacia in dogs: 12 cases (1997–2008). J Am Vet Med Assoc. 2010; 237(10), 1160–1165. doi: 10.2460/javma.237.10.1160 [PubMed]
54. Greitz D. Unraveling the riddle of syringomyelia. Neurosurg Rev. 2006; 29(4), 251–264. doi: 10.1007/s10143-006-0029-5 [PubMed]
55. Norenberg MD, Smith J, Marcillo A. The pathology of human spinal cord injury: defining the problems. J Neurotrauma. 2004; 21(4), 429–440. doi: 10.1089/089771504323004575 [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science